Alignment Healthcare (ALHC) Cash & Equivalents (2020 - 2026)

Alignment Healthcare has reported Cash & Equivalents for 7 years, with the latest figure at $705.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 58.14% year-over-year to $705.6 million; the trailing twelve-month figure through Mar 2026 stood at $705.6 million (up 58.14% YoY), and the FY2025 full-year result was $575.8 million, up 33.03% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $705.6 million, up from $575.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $705.6 million in Q1 2026, with the low at $202.9 million in Q4 2023.
• Historically, Cash & Equivalents has averaged $436.5 million across 5 years, with a median of $432.9 million in 2024.
• Annual changes were most pronounced in 2023 — Cash & Equivalents plunged 50.46% — and 2024, when it soared 113.33%.
• Alignment Healthcare's Cash & Equivalents stood at $409.5 million in 2022, then sank by 50.46% to $202.9 million in 2023, then soared by 113.33% to $432.9 million in 2024, then surged by 33.03% to $575.8 million in 2025, then advanced by 22.54% to $705.6 million in 2026.
• The last three Cash & Equivalents figures came in at $705.6 million (Q1 2026), $575.8 million (Q4 2025), and $618.1 million (Q3 2025), per Business Quant data.